+1 (646) 663-5829 | +91 702 496 8807

  sales@regionalresearchreports.com

Pulmonary Hypertension Drug Market Size, Share, and COVID-19 Impact Analysis by Drug Type, Type, Route of Administration, Regions, Company Market Share, and Regional Forecast, 2022-2030

Publish Date: Jan 2025
Report ID:HC-8836
Base Year:2024
Report Format:PDF, Excel
Report Pages:178
Region:Global

  1. Global Pulmonary Hypertension Drug Market Introduction and Market Overview
    1. Objective of the Study
    2. Global Pulmonary Hypertension Drug Market Scope and Market Estimation
      1. Global Pulmonary Hypertension Drug Market Overall Market Size (US$ Mn), Market CAGR (%), Market Forecast (2023-2033)
      2. Global Pulmonary Hypertension Drug Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2018-2033
    3. Market Segmentation
      1. Drug Type of Global Pulmonary Hypertension Drug Market
      2. Type of Global Pulmonary Hypertension Drug Market
      3. Route of Administration of Global Pulmonary Hypertension Drug Market
      4. Region of Global Pulmonary Hypertension Drug Market
  2. Global Pulmonary Hypertension Drug Market - Executive Summary
    1. Key Findings
      1. Top Impacting Factors
      2. Top Investment Pockets         
      3. Market Attractiveness Analysis         
    2. Key Companies Introduction
  3. Market Factor Analysis
    1. Global Pulmonary Hypertension Drug Market Industry Development Trends under COVID-19 Outbreak
      1. Global COVID-19 Status Overview
      2. Influence of COVID-19 Outbreak on Global Pulmonary Hypertension Drug Market Industry Development
    2. Market Dynamics (Growth Influencers)
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Impact Analysis of Drivers and Restraints
    3. Ecosystem/ Value Chain Analysis
    4. Porter’s Five Forces Analysis
    5. SWOT Analysis
    6. PEST Analysis
    7. Market Opportunity Assessment – by Region (North America/ Europe/ Asia Pacific/ Middle East and Africa/ South America)
      1. By Drug Type
      2. By Type
      3. By Route of Administration
  4. Global Pulmonary Hypertension Drug Market: Estimates and Historic Trend Analysis (2018-2021)
  5. Global Pulmonary Hypertension Drug Market Estimates and Forecast Trend Analysis, by Drug Type
    1. Pulmonary Hypertension Drug Market Share (%) Estimates and Forecasts, by Drug Type, 2022, 2023 and 2033
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Pulmonary Hypertension Drug Market Revenue (US$ Mn) Estimates and Forecasts, by Drug Type, 2023 to 2033
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Endothelin Receptor Antagonists (ERAs)
    4. PDE-5 Inhibitors
    5. Prostacyclin and Prostacyclin Analogs
    6. SGC Stimulators
  6. Global Pulmonary Hypertension Drug Market Estimates and Forecast Trend Analysis, by Type
    1. Pulmonary Hypertension Drug Market Share (%) Estimates and Forecasts, by Type, 2022, 2023 and 2033
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Pulmonary Hypertension Drug Market Revenue (US$ Mn) Estimates and Forecasts, by Type, 2023 to 2033
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Branded
    4. Generics
  7. Global Pulmonary Hypertension Drug Market Estimates and Forecast Trend Analysis, by Route of Administration
    1. Pulmonary Hypertension Drug Market Share (%) Estimates and Forecasts, by Route of Administration, 2022, 2023 and 2033
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Pulmonary Hypertension Drug Market Revenue (US$ Mn) Estimates and Forecasts, by Route of Administration, 2023 to 2033
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Oral
    4. Intravenous/ subcutaneous
    5. Inhalational
  8. Global Pulmonary Hypertension Drug Market Analysis and Forecast, by Region
    1. Pulmonary Hypertension Drug Market Share (%) Estimates and Forecasts, by Region, 2022, 2023 and 2033
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Pulmonary Hypertension Drug Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2023 to 2033
      1. Key Market Trends, Growth Factors, and Opportunities
      2. North America
      3. Europe
      4. Asia Pacific
      5. Middle East and Africa
      6. South America
  9. North America Pulmonary Hypertension Drug Market: Estimates and Forecast Trend Analysis
    1. North America Market Assessments and Key Findings
    2. North America Pulmonary Hypertension Drug Market Share (%) Estimates and Forecasts, 2022, 2023 and 2033
    3. North America Pulmonary Hypertension Drug Market Size Estimates and Forecast (US$ Million) (2023 to 2033)
      1. By Drug Type
      2. By Type
      3. By Route of Administration
      4. By Country
        1. U.S.
        2. Canada
        3. Mexico
  10. Europe Pulmonary Hypertension Drug Market: Estimates and Forecast Trend Analysis
    1. Europe Market Assessments and Key Findings
    2. Europe Pulmonary Hypertension Drug Market Share (%) Estimates and Forecasts, 2022, 2023 and 2033
    3. Europe Pulmonary Hypertension Drug Market Size Estimates and Forecast (US$ Million) (2023 to 2033)
      1. By Drug Type
      2. By Type
      3. By Route of Administration
      4. By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Russia
        7. Rest of Europe
  11. Asia Pacific Pulmonary Hypertension Drug Market: Estimates and Forecast Trend Analysis
    1. Asia Pacific Market Assessments and Key Findings
    2. Asia Pacific Pulmonary Hypertension Drug Market Share (%) Estimates and Forecasts, 2022, 2023 and 2033
    3. Asia Pacific Market Size Estimates and Forecast (US$ Million) (2023 to 2033)
      1. By Drug Type
      2. By Type
      3. By Route of Administration
      4. By Country
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
  12. Middle East and Africa Pulmonary Hypertension Drug Market: Estimates and Forecast Trend Analysis
    1. Middle East and Africa Market Assessments and Key Findings
    2. Middle East and Africa Pulmonary Hypertension Drug Market Share (%) Estimates and Forecasts, 2022, 2023 and 2033
    3. Middle East and Africa Market Size Estimates and Forecast (US$ Million) (2023 to 2033)
      1. By Drug Type
      2. By Type
      3. By Route of Administration
      4. By Country
        1. U.A.E.
        2. Saudi Arabia
        3. Egypt
        4. South Africa
        5. Rest of Middle East and Africa
  13. South America Pulmonary Hypertension Drug Market: Estimates and Forecast Trend Analysis
    1. South America Market Assessments and Key Findings
    2. South America Pulmonary Hypertension Drug Market Share (%) Estimates and Forecasts, 2022, 2023 and 2033
    3. South America Market Size Estimates and Forecast (US$ Million) (2023 to 2033)
      1. By Drug Type
      2. By Type
      3. By Route of Administration
      4. By Country
        1. Brazil
        2. Argentina
        3. Colombia
        4. Rest of South America
  14. Manufacturing Cost Structure Analysis
    1. Raw Material and Suppliers
    2. Manufacturing Cost Structure Analysis of Pulmonary Hypertension Drug Market
    3. Manufacturing Process Analysis of Pulmonary Hypertension Drug Market
    4. Industry Chain Structure of Pulmonary Hypertension Drug Market
  15. Marketing, Distributors and Customer
    1. Sales Channel
      1. Direct Channels
      2. Indirect Channels
    2. Pulmonary Hypertension Drug Market Distributors
    3. Pulmonary Hypertension Drug Market Customer
  16. Competition Landscape
    1. Key Manufacturers Pulmonary Hypertension Drug Market Producing Area Distribution, Sales Area, Product
    2. Key Manufacturers Pulmonary Hypertension Drug Market Product Location Distribution
    3. Market Competition Matrix, by Leading Players
      1. Competition Landscape Analysis
      2. Concentration Ratio (CR3, CR5 and CR10) and (2020-2022)
    4. List of Emerging, Prominent and Leading Players
    5. Major Mergers and Acquisitions, Partnership, Joint Venture, Expansions, Deals, Etc.
  17. Company Profiles
    1. United Therapeutics Corporation
      1.  Company Overview
      2. Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4. Product Portfolio - Product Category, Type, and Specification
      5. Product Suppliers and Distributors
      6. Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8. Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9. SWOT Analysis
      10.  Strategic Initiatives
    2. Bayer AG
      1. Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
    3. Gilead Sciences Inc.
      1.  Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
    4. Johnson  Johnson
      1. Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
    5. Viatris Inc.
      1. Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
    6. GlaxoSmithKline
      1. Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
    7. Novartis
      1.  Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
    8. Lupin Pharmaceuticals Inc.
      1. Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
    9. Sun Pharmaceutical Industries Inc.
      1. Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
    10. Teva Pharmaceutical Industries Ltd.
      1.  Company Overview
      2.  Financial Performance (2018-2022, USD Million)
      3.  Geographical Footprint Analysis
      4.  Product Portfolio - Product Category, Type, and Specification
      5.  Product Suppliers and Distributors
      6.  Key Recent Development (2018-2023)
      7.  Top Wining Strategies
      8.  Partnerships/Collaboration/Merger/Acquisition/Expansion/Others
      9.  SWOT Analysis
      10.  Strategic Initiatives
  18. Assumptions and Research Methodology
  19. Conclusions and Recommendations
    1. Analysis and Suggestions on New Project Investment
    2. Research Findings and Conclusion
  1. Global Pulmonary Hypertension Drug Market Historic Analysis (US$ Mn), 2018-2022
  2. Global Pulmonary Hypertension Drug Market Forecast Opportunity Analysis (US$ Mn), 2023-2033
  3. Global Pulmonary Hypertension Drug Market Absolute $ Opportunity
  4. Global Pulmonary Hypertension Drug Market Analysis by Drug Type, 2023-2033
  5. Global Pulmonary Hypertension Drug Market Analysis by Type, 2023-2033
  6. Global Pulmonary Hypertension Drug Market Analysis by Route of Administration, 2023-2033
  7. Global Pulmonary Hypertension Drug Market Analysis by Region, 2023-2033
  8. North America Pulmonary Hypertension Drug Market Absolute $ Opportunity
  9. North America Pulmonary Hypertension Drug Market Analysis by Drug Type, 2023-2033
  10. North America Pulmonary Hypertension Drug Market Analysis by Type, 2023-2033
  11. North America Pulmonary Hypertension Drug Market Analysis by Route of Administration, 2023-2033
  12. North America Pulmonary Hypertension Drug Market Analysis by Country, 2023-2033
  13. South America Pulmonary Hypertension Drug Market Absolute $ Opportunity
  14. South America Pulmonary Hypertension Drug Market Analysis by Drug Type, 2023-2033
  15. South America Pulmonary Hypertension Drug Market Analysis by Type, 2023-2033
  16. South America Pulmonary Hypertension Drug Market Analysis by Route of Administration, 2023-2033
  17. South America Pulmonary Hypertension Drug Market Analysis by Country, 2023-2033
  18. Europe Pulmonary Hypertension Drug Market Absolute $ Opportunity
  19. Europe Pulmonary Hypertension Drug Market Analysis by Drug Type, 2023-2033
  20. Europe Pulmonary Hypertension Drug Market Analysis by Type, 2023-2033
  21. Europe Pulmonary Hypertension Drug Market Analysis by Route of Administration, 2023-2033
  22. Europe Pulmonary Hypertension Drug Market Analysis by Country, 2023-2033
  23. Asia Pacific Pulmonary Hypertension Drug Market Absolute $ Opportunity
  24. Asia Pacific Pulmonary Hypertension Drug Market Analysis by Drug Type, 2023-2033
  25. Asia Pacific Pulmonary Hypertension Drug Market Analysis by Type, 2023-2033
  26. Asia Pacific Pulmonary Hypertension Drug Market Analysis by Route of Administration, 2023-2033
  27. Asia Pacific Pulmonary Hypertension Drug Market Analysis by Country, 2023-2033
  28. MEA Pulmonary Hypertension Drug Market Absolute $ Opportunity
  29. MEA Pulmonary Hypertension Drug Market Analysis by Drug Type, 2023-2033
  30. MEA Pulmonary Hypertension Drug Market Analysis by Type, 2023-2033
  31. MEA Pulmonary Hypertension Drug Market Analysis by Route of Administration, 2023-2033
  32. MEA Pulmonary Hypertension Drug Market Analysis by Country, 2023-2033

List of Figures

  1. Global Pulmonary Hypertension Drug Market Historic Y-o-Y Analysis (%), 2018-2022
  2. Global Pulmonary Hypertension Drug Market Forecast Y-o-Y Analysis (%), 2023-2033
  3. Global Pulmonary Hypertension Drug Market Share Analysis by Drug Type, 2022, 2023, and 2033
  4. Global Pulmonary Hypertension Drug Market Share Analysis by Type, 2022, 2023, and 2033
  5. Global Pulmonary Hypertension Drug Market Share Analysis by Route of Administration, 2022, 2023, and 2033
  6. Global Pulmonary Hypertension Drug Market Share Analysis by Region, 2022, 2023, and 2033
  7. North America Pulmonary Hypertension Drug Market Share Analysis by Drug Type, 2022, 2023, and 2033
  8. North America Pulmonary Hypertension Drug Market Share Analysis by Type, 2022, 2023, and 2033
  9. North America Pulmonary Hypertension Drug Market Share Analysis by Route of Administration, 2022, 2023, and 2033
  10. North America Pulmonary Hypertension Drug Market Share Analysis by Country, 2022, 2023, and 2033
  11. South America Pulmonary Hypertension Drug Market Share Analysis by Drug Type, 2022, 2023, and 2033
  12. South America Pulmonary Hypertension Drug Market Share Analysis by Type, 2022, 2023, and 2033
  13. South America Pulmonary Hypertension Drug Market Share Analysis by Route of Administration, 2022, 2023, and 2033
  14. South America Pulmonary Hypertension Drug Market Share Analysis by Country, 2022, 2023, and 2033
  15. Europe Pulmonary Hypertension Drug Market Share Analysis by Drug Type, 2022, 2023, and 2033
  16. Europe Pulmonary Hypertension Drug Market Share Analysis by Type, 2022, 2023, and 2033
  17. Europe Pulmonary Hypertension Drug Market Share Analysis by Route of Administration, 2022, 2023, and 2033
  18. Europe Pulmonary Hypertension Drug Market Share Analysis by Country, 2022, 2023, and 2033
  19. Asia Pacific Pulmonary Hypertension Drug Market Share Analysis by Drug Type, 2022, 2023, and 2033
  20. Asia Pacific Pulmonary Hypertension Drug Market Share Analysis by Type, 2022, 2023, and 2033
  21. Asia Pacific Pulmonary Hypertension Drug Market Share Analysis by Route of Administration, 2022, 2023, and 2033
  22. Asia Pacific Pulmonary Hypertension Drug Market Share Analysis by Country, 2022, 2023, and 2033
  23. MEA Pulmonary Hypertension Drug Market Share Analysis by Drug Type, 2022, 2023, and 2033
  24. MEA Pulmonary Hypertension Drug Market Share Analysis by Type, 2022, 2023, and 2033
  25. MEA Pulmonary Hypertension Drug Market Share Analysis by Route of Administration, 2022, 2023, and 2033
  26. MEA Pulmonary Hypertension Drug Market Share Analysis by Country, 2022, 2023, and 2033
market statsville report image

Want to Review Complete Market Research Report

Request Sample
$3150  $2950 save 23%
$4950  $3250 save 25%
$7680  $4450 save 30%
Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Budget constrains? Get in touch with us for special pricing
Request Discount

Phone: +1 (888) 615 4898

Email: sales@regionalresearchreports.com

Chat with Us: Click here to start